The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if the agent, Floseal, can decrease the amount of blood patients lose after total knee replacement (TKR) surgery. If this product can be found to have an effect on bleeding, it may potentially reduce the problems associated with bleeding after knee replacement surgery such as pain, stiffness, and the need to have a blood transfusion. The subject's overall participation will be over a period of 6 weeks.

Clinical Trial Description

This is a prospective double blind randomized clinical trial of patients requiring unilateral total knee arthroplasty. The patients will be randomized intra-operatively to receiving Floseal or no treatment.

Both the patient and the observers will be blinded to whether the subject received Floseal or no treatment. Only the operating surgeons will be aware of whether Floseal or no treatment was given.

As was performed in the pilot study, randomization of Floseal or no treatment will be performed using the sealed envelope technique. Randomization will occur at the time of surgery. The statistician is responsible for maintaining the randomization schedule and issuing the sealed envelopes. The inner envelope will contain whether Floseal or no treatment is to be given on a card which will be counter-signed by the surgeon at the time of surgery. The inner envelope will then be sealed, followed by sealing of the outer envelope. Following the procedure, the surgeon will then take the sealed and signed envelope to surgeon who will store and file it in a locked cabinet in his office. The patients study number will be on the outside surface of the envelopes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00990288
Study type	Interventional
Source	Hospital for Special Surgery, New York
Contact
Status	Completed
Phase	Phase 4
Start date	October 2007
Completion date	August 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04588350` - Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery	N/A
Completed	`NCT05426564` - Exploratory Assessment of the Quantra® System in Adult ECMO Patients
Active, not recruiting	`NCT05492214` - The Effect of Time Window for Umbilical Cord Clamping During Cesareans on Offspring Hemoglobin and Maternal Blood Loss	N/A
Withdrawn	`NCT05518279` - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures	Phase 3
Enrolling by invitation	`NCT02910115` - Cooling the Uterus in C-section After Dysfunctional Labor	N/A
Completed	`NCT02569658` - Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty	N/A
Completed	`NCT01048658` - Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures	Phase 4
Terminated	`NCT02908516` - Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures	Phase 4
Completed	`NCT04089865` - Oral Versus Intravenous Tranexamic Acid	Phase 4
Recruiting	`NCT02265562` - Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy	Phase 3
Completed	`NCT02312440` - Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty	Phase 3
Completed	`NCT02083809` - Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation	N/A
Completed	`NCT01895101` - The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients	Phase 4
Completed	`NCT01099475` - Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery	N/A
Completed	`NCT03365999` - Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.	Phase 2
Recruiting	`NCT05550623` - Pneumatic Tourniquet Versus no Tourniquet in Transfemoral Amputation	N/A
Completed	`NCT05012202` - Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women
Completed	`NCT02311309` - Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery	N/A
Withdrawn	`NCT01712971` - Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery	N/A
Completed	`NCT01646060` - Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw	Phase 1